掺入5-甲基胞苷减轻RIG-I介导的自我扩增RNA疫苗固有免疫应答
本研究探究自我扩增RNA(saRNA)疫苗中掺入5-甲基胞苷(5mC)减轻不良反应的机制。发现5mC掺入使抗原表达持久而强烈,在浆细胞样树突状细胞(pDC)中减弱I型干扰素诱导,从而减轻体内过度固有免疫应答,同时不损害针对SARS-CoV-2 RBD的B细胞和T细胞应答。机制上,pDC对未修饰saRNA的识别由RIG-I介导,5mC掺入消除了该识别;saRNA-5mC以不依赖RIG-I的方式在巨噬细胞等专职抗原提呈细胞中诱导强烈固有免疫激活。
要点
- 5mC掺入saRNA在pDC中减弱I型干扰素诱导,减轻体内过度固有免疫应答。
- saRNA-5mC不损害针对SARS-CoV-2 RBD的B细胞和T细胞应答。
- pDC对未修饰saRNA的识别由RIG-I介导,5mC掺入消除该识别。
核心结论
- 5mC掺入通过消除pDC中RIG-I对saRNA的识别来减轻固有免疫应答,同时维持抗原表达和适应性免疫应答,支持saRNA-5mC疫苗平台的潜在临床使用。
研究设计与样本
- 本研究为机制研究,基于既往开发的表达SARS-CoV-2刺突蛋白膜锚定受体结合域(S-RBD-TM)的saRNA疫苗及掺入5mC的saRNA(saRNA-5mC),探究5mC掺入减轻不良反应而维持免疫原性的机制。
主要发现
- 5mC掺入saRNA导致抗原表达持久而强烈,并减弱I型干扰素诱导,特异性发生于浆细胞样树突状细胞(pDC)。
- saRNA-5mC减轻体内过度固有免疫应答,而不损害针对SARS-CoV-2 RBD的B细胞和T细胞应答。
- pDC对未修饰saRNA的识别由宿主胞质RNA传感器RIG-I介导,5mC掺入消除了该识别。
- saRNA-5mC以不依赖RIG-I的方式在巨噬细胞等专职抗原提呈细胞中诱导强烈固有免疫激活。
临床怎么用
- 作者认为本研究支持saRNA-5mC疫苗平台的潜在临床使用。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
To improve existing synthetic RNA-based vaccines, we previously developed a self-amplifying RNA (saRNA)-based vaccine expressing a membrane-anchored (TM) receptor binding domain (RBD) of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spike (S) protein (S-RBD-TM) and demonstrated that a low dose of this saRNA vaccine elicits robust immune responses. Moreover, a recent clinical trial with an saRNA vaccine incorporating 5-methylcytidine (5mC) (saRNA-5mC) has demonstrated reduced vaccine reactogenicity while maintaining robust humoral responses. In this study, we investigate the mechanisms by which 5mC incorporation attenuates adverse effects while maintaining immunogenicity. We found that incorporation of 5mC into the saRNA platform led to prolonged and robust expression of antigen and attenuated induction of type I interferon, a key driver of reactogenicity, specifically in plasmacytoid dendritic cells (pDCs). As a result, saRNA-5mC alleviated excessive innate immune responses in vivo without impairing B cell and T cell responses against the SARS-CoV-2 RBD. Mechanistically, we demonstrated that the detection of unmodified saRNA in pDCs was mediated by a host cytosolic RNA sensor, RIG-I, and this sensing was abolished with 5mC incorporation. In contrast, saRNA-5mC induced robust innate activation in professional antigen-presenting cells, such as macrophages, in a RIG-I-independent manner, highlighting distinct host sensing mechanisms for synthetic RNAs. Our study provides support for the potential clinical use of saRNA-5mC vaccine platforms.
引用
- Akahata W, Komori M, Morey AL, et al. Incorporation of 5-methylcytidine alleviates RIG-I-mediated innate immune responses to a self-amplifying RNA vaccine. Sci Transl Med. 2025. PMID: 41223248. doi:10.1126/scitranslmed.adz2276
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。